(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GOGLICO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

GOGLICO

ST13

US500000079195459

Class

5, 10

Filing

79195459

Registration

5293459

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

02/21/2025

Classification

Registered

Trademark type

Word

Nice classes

5, 10

Filing date

07/11/2016

Registration date

09/26/2017

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/12/2024

Last transaction

02/21/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

01

Owner location

PT

Examiner

SHANOSKI,JOANNA MARIE

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

C. P. (pessoa física)

Representatives

John Alumit ALUMIT IP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Glucose for use as an additive to foods for medical purposes; nutritional supplements for medical purposes; cachets for pharmaceutical purposes; gelatin for medical purposes; medicinal healthcare preparations for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct the hypoglycemia; chemical preparations for medical purposesnamely to correct hypoglycemias or other diseases that imply the need of sugar or similar substances to correct imbalances; bracelets for medical purposes; empty capsules for pharmaceuticals; pharmaceutical compositionsnamely preparations with glycose to allow correcting hypoglycemia in diabetics or hypotensives; medicated lozenges; Pharmaceutical preparationselixirs for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemia; anti-diabetic pharmaceuticals; autonomic drugs for medical purposes; glucose for medical purposes; anti-diabetic preparations; cardiovascular treatment preparations; glucose preparations for medical purposes; pharmaceutical preparations and substances for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemia; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for human use for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct the hypoglycemia; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparationsfor the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemia; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of disorders of the endocrine system; chemico-pharmaceutical preparations for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemia

Class 10

Wrist braces for medical use; applicators for medications sold emptyapplicators transported close to the body containing glycose in a capsule to allow the user to correct hypoglycemia; applicators for pharmaceutical preparations sold emptyapplicators transported close to the body containing glycose in a capsule to allow the user to correct hypoglycemia; medical braces for application to the human bodyaround the armforearm or wrist

Publications

History of USPTO decisions and trademark events.

34 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

02/21/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/05/2025

INPC

INVALIDATION PROCESSED

02/05/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

12/13/2024

C71T

CANCELLED SECTION 71

04/12/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/26/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/02/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/11/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/29/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/16/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/16/2018

FIMP

FINAL DISPOSITION PROCESSED

01/16/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/26/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

09/26/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/11/2017

PUBO

PUBLISHED FOR OPPOSITION

07/11/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/21/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/30/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

05/30/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/30/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

05/30/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/30/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/29/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/28/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/28/2017

RFNT

REFUSAL PROCESSED BY IB

12/24/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/02/2016

RFRR

REFUSAL PROCESSED BY MPU

12/02/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/12/2016

CNRT

NON-FINAL ACTION WRITTEN

11/11/2016

MAFR

APPLICATION FILING RECEIPT MAILED

11/11/2016

DOCK

ASSIGNED TO EXAMINER

11/07/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/07/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/03/2016

Continuous trademark protection

Get notified about every new filing that threatens GOGLICO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.